Abstract
The premise for periodontal therapy is to control deregulated immune response and dysbiotic microbiome to sustain a balanced tissue homeostasis and achieve regeneration of the lost tissues. Over the years, our understanding of the pathogenesis of periodontitis changed from one being an infectious disease of solely bacterial origin to the one being a non-resolving inflammatory process to a diverse group of dysbiotic microbial species which is driven by genetic, environmental, local, and systemic factors. This paradigm shift from infectious to inflammatory diseases combined with rising concerns for antibiotic resistance worldwide changed the philosophy of periodontal patient management from one treatment for all approach and fostered research to identify more individualized strategies to control the inflammatory component of the disease either through targeting host immune response and/or modulating microbiome. Similarly, considerable progress has been made in periodontal regenerative medicine through promising research on protein and cell-based therapies, 3D printing, and laser therapy. Clinicians and researchers are now facing a new challenge as the increased lifespan and the growing number of implant-supported restorations change the clinical landscape which demands more investigations toward understanding the physiology of aging and defining the pathogenesis and risk for implant diseases. The era of “precision periodontics” will include personalized strategies for the prevention of periodontal and peri-implant diseases and tailored therapies toward individuals’ unique biology and risk profiles, which will take into consideration many elements in clinical decision making including changes in microbiome, genetic and epigenetic factors, environmental and systemic perturbations, and lifestyle preferences.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Knight ET, Liu J, Seymour GJ, Faggion CM Jr, Cullinan MP. Risk factors that may modify the innate and adaptive immune responses in periodontal diseases. Periodontol 2000. 2016;71(1):22–51.
Eke PI, Wei L, Borgnakke WS, Thornton-Evans G, Zhang X, Lu H, et al. Periodontitis prevalence in adults ≥ 65 years of age, in the USA. Periodontol 2000. 2016;72(1):76–95.
Kocher T, Konig J, Borgnakke WS, Pink C, Meisel P. Periodontal complications of hyperglycemia/diabetes mellitus: epidemiologic complexity and clinical challenge. Periodontol 2000. 2018;78(1):59–97.
Reynolds MA. Modifiable risk factors in periodontitis: at the intersection of aging and disease. Periodontol 2000. 2014;64(1):7–19.
Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000. 2013;62(1):59–94.
Suvan JE, Finer N, D’Aiuto F. Periodontal complications with obesity. Periodontol 2000. 2018;78(1):98–128.
Dommisch H, Kuzmanova D, Jonsson D, Grant M, Chapple I. Effect of micronutrient malnutrition on periodontal disease and periodontal therapy. Periodontol 2000. 2018;78(1):129–53.
Crump KE, Sahingur SE. Microbial nucleic acid sensing in oral and systemic diseases. J Dent Res. 2016;95(1):17–25.
Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015;86(5):611–22.
Ebersole JL, Dawson DA 3rd, Emecen Huja P, Pandruvada S, Basu A, Nguyen L, et al. Age and periodontal health—immunological view. Curr Oral Health Rep. 2018;5(4):229–41.
Lamster IB, Asadourian L, Del Carmen T, Friedman PK. The aging mouth: differentiating normal aging from disease. Periodontol 2000. 2016;72(1):96–107.
Fiorellini JP, Luan KW, Chang YC, Kim DM, Sarmiento HL. Peri-implant mucosal tissues and inflammation: clinical implications. Int J Oral Maxillofac Implants. 2019;34:s25–33.
Smith MM, Knight ET, Al-Harthi L, Leichter JW. Chronic periodontitis and implant dentistry. Periodontol 2000. 2017;74(1):63–73.
Bartold PM. Lifestyle and periodontitis: the emergence of personalized periodontics. Periodontol 2000. 2018;78(1):7–11.
Kornman KS. Traditional and emerging diagnostic strategies for identifying risk. Compend Contin Educ Dent. 2014;35(Suppl 3):12–5. quiz 6-7.
Kornman KS, Duff GW. Personalized medicine: will dentistry ride the wave or watch from the beach? J Dent Res. 2012;91(Suppl 7):8S–11S.
Moreno Sancho F, Leira Y, Orlandi M, Buti J, Giannobile WV, D’Aiuto F. Cell-based therapies for alveolar bone and periodontal regeneration: concise review. Stem Cells Transl Med. 2019;8(12):1286–95.
Giannobile WV, Hollister SJ, Ma PX. Future prospects for periodontal bioengineering using growth factors. Clin Adv Periodontics. 2011;1(2):88–94.
Lang NP, Salvi GE, Sculean A. Nonsurgical therapy for teeth and implants-when and why? Periodontol 2000. 2019;79(1):15–21.
Jepsen S, Berglundh T, Genco R, Aass AM, Demirel K, Derks J, et al. Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015;42(Suppl 16):S152–7.
Albandar JM. Adjunctive antibiotics with nonsurgical periodontal therapy improve the clinical outcome of chronic periodontitis in current smokers. J Evid Based Dent Pract. 2011;11(3):137–40.
Kornman KS, Giannobile WV, Duff GW. Quo vadis: what is the future of periodontics? How will we get there? Periodontol 2000. 2017;75(1):353–71.
Kornman KS, Van Dyke TE. Bringing light to the heat: “inflammation and periodontal diseases: a reappraisal”. J Periodontol. 2008;79(8):1313.
Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res. 2003;82(2):82–90.
Van Dyke TE, van Winkelhoff AJ. Infection and inflammatory mechanisms. J Periodontol. 2013;84(Suppl 4):S1–7.
Sahingur SE, Yeudall WA. Chemokine function in periodontal disease and oral cavity cancer. Front Immunol. 2015;6:214.
Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Investig. 1976;34(3):235–49.
Page RC, Schroeder HE. Current status of the host response in chronic marginal periodontitis. J Periodontol. 1981;52(9):477–91.
Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000. 1997;14:33–53.
Page RC, Kornman KS. The pathogenesis of human periodontitis: an introduction. Periodontol 2000. 1997;14:9–11.
Hajishengallis G, Korostoff JM. Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later. Periodontol 2000. 2017;75(1):116–51.
Bartold PM, Van Dyke TE. Host modulation: controlling the inflammation to control the infection. Periodontol 2000. 2017;75(1):317–29.
Hajishengallis G, Sahingur SE. Novel inflammatory pathways in periodontitis. Adv Dent Res. 2014;26(1):23–9.
Hajishengallis G, Li X, Mitroulis I, Chavakis T. Trained innate immunity and its implications for mucosal immunity and inflammation. Adv Exp Med Biol. 2019;1197:11–26.
Graves DT, Oates T, Garlet GP. Review of osteoimmunology and the host response in endodontic and periodontal lesions. Journal of Oral Microbiology 2011;3:5304. https://doi.org/10.3402/jom.v3i0.5304.
Loe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol. 1965;36:177–87.
Theilade E. The non-specific theory in microbial etiology of inflammatory periodontal diseases. J Clin Periodontol. 1986;13(10):905–11.
Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res. 1994;8(2):263–71.
Van Dyke TE. The etiology and pathogenesis of periodontitis revisited. J Appl Oral Sci. 2009;17(1):i. https://doi.org/10.1590/S1678-77572009000100001.
Kornman KS. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis. 1999;28(3):520–6.
Van Dyke TE. Inflammation and periodontal diseases: a reappraisal. J Periodontol. 2008;79(Suppl 8):1501–2.
Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10(10):717–25.
Lamont RJ, Hajishengallis G. Polymicrobial synergy and dysbiosis in inflammatory disease. Trends Mol Med. 2015;21(3):172–83.
Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000. 2013;62(1):203–17.
Giannobile WV, McClain PK. Enhancing periodontal health through regenerative approaches. J Periodontol. 2015;86(Suppl 2):S1–3.
Yanine N, Araya I, Brignardello-Petersen R, Carrasco-Labra A, Gonzalez A, Preciado A, et al. Effects of probiotics in periodontal diseases: a systematic review. Clin Oral Investig. 2013;17(7):1627–34.
Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontol 2000. 2016;71(1):82–112.
Preshaw PM. Host modulation therapy with anti-inflammatory agents. Periodontol 2000. 2018;76(1):131–49.
Yen CA, Damoulis PD, Stark PC, Hibberd PL, Singh M, Papas AS. The effect of a selective cyclooxygenase-2 inhibitor (celecoxib) on chronic periodontitis. J Periodontol. 2008;79(1):104–13.
Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000. 2007;43:294–315.
Hajishengallis G, Hajishengallis E, Kajikawa T, Wang B, Yancopoulou D, Ricklin D, et al. Complement inhibition in pre-clinical models of periodontitis and prospects for clinical application. Semin Immunol. 2016;28(3):285–91.
Van Dyke TE. Pro-resolving mediators in the regulation of periodontal disease. Mol Asp Med. 2017;58:21–36.
Alani A, Seymour R. Systemic medication and the inflammatory cascade. Periodontol 2000. 2014;64(1):198–210.
Shungin D, Haworth S, Divaris K, Agler CS, Kamatani Y, Keun Lee M, et al. Genome-wide analysis of dental caries and periodontitis combining clinical and self-reported data. Nat Commun. 2019;10(1):2773.
Kornman KS, Polverini PJ. Clinical application of genetics to guide prevention and treatment of oral diseases. Clin Genet. 2014;86(1):44–9.
Asa’ad F, Monje A, Larsson L. Role of epigenetics in alveolar bone resorption and regeneration around periodontal and peri-implant tissues. Eur J Oral Sci. 2019;127(6):477–93.
Persson GR. Periodontal complications with age. Periodontol 2000. 2018;78(1):185–94.
Acknowledgement
Dr. Sahingur is supported by the grants from the U.S. National Institutes of Health DE025037 and DE027374. Dr. Yajie Li and Ms. Erin Mooney assisted with the preparation of Fig. 1.1. There are no conflicts of financial interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sahingur, S.E. (2020). Evolving Paradigms in the Pathogenesis and Management of Periodontitis. In: Sahingur, S. (eds) Emerging Therapies in Periodontics. Springer, Cham. https://doi.org/10.1007/978-3-030-42990-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-42990-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42989-8
Online ISBN: 978-3-030-42990-4
eBook Packages: MedicineMedicine (R0)